Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order to KC Park, the winner of this year's OXION Poster Prize.

The annual OXION symposium on Membrane Transport proteins (ion channels and transporters), an inter-departmental consortium of PhD students, has been running for the last 17 years. OXION, The Integrative Physiology Initiative in Ion Channels and Diseases of Electrically Excitable Cells, was one of three awards made by the Wellcome Trust in 2002 to promote integrative physiology. The programme is led by our department's GlaxoSmithKline Royal Society Professor Dame Frances Ashcroft FRS.

This year, KC Park from the Swietach and Smart Groups has been awarded the poster prize for his work entitled “Propionate anions accumulated in propionic acidaemia results in sustained remodelling of cardiac epigenetics and excitation-contraction coupling”.

Propionate is a naturally-produced metabolite which accumulates to toxic levels in propionic acidaemia (PA), a fatal inborn error of metabolism. A characteristic feature of PA is the development of cardiomyopathy and arrhythmias, but the mechanism is unknown. Data from KC and his team suggests that propionate induces cardiac dysfunction by acting as an epigenetic modifier of key genes involved in excitation-contraction coupling, the process by which the heartbeat is triggered, which undergoes remodelling in numerous diseases.

His poster prize of £125 is sponsored by Autifony Therapeutics.

More information about KC and his research can be found here.

 

Similar stories

New target to develop immunosuppressants

Publication Research

A new study from the Parekh Group has resolved a long-standing question in our understanding of intracellular Ca2+ signalling, namely how a specific type of Ca2+ channel is uniquely able to signal to the nucleus to regulate gene expression. By unravelling this mechanism, researchers have identified a new approach for developing immunosuppressant drugs.

How the kidney contributes to healthy iron levels and disease

Lakhal-Littleton Group News Publication Research

A new study from the Lakhal-Littleton Group has addressed a long-standing gap in our understanding of systemic iron homeostasis. It provides the first formal demonstration that the hormone hepcidin controls iron reabsorption in the kidney, in a manner that impacts the body’s iron levels, under normal physiological conditions. It also demonstrates for the first time how this mechanism becomes critically important in the development of iron disorders.

Scott Waddell honoured by the Academy of Medical Sciences

Awards and Honours Head of Department's News

Congratulations are in order to Professor Scott Waddell FMedSci on his election to The Academy of Medical Sciences.

Nchimunya Nelisa Tebeka wins Diabetes UK Early Career Investigator Award

Awards and Honours EDI News Students

Congratulations are in order to Rhodes Scholar Nchimunya Nelisa Tebeka, who has been awarded this year's Diabetes UK Early Career Investigator Award for her DPhil work. This award is awarded for the best basic or clinical science oral abstract presentation at the Diabetes UK Professional Conference.

New research to radically alter our understanding of synaptic development

Publication Research

A new study from the Molnár group on the role of regulated synaptic vesicular release in specialised synapse formation has made it to the cover of Cerebral Cortex.